Search results
Results from the WOW.Com Content Network
Cyclohexanone is produced by the oxidation of cyclohexane in air, typically using cobalt catalysts: [11]. C 6 H 12 + O 2 → (CH 2) 5 CO + H 2 O. This process forms cyclohexanol as a by-product, and this mixture, called "KA Oil" for ketone-alcohol oil, is the main feedstock for the production of adipic acid.
Ethenone is a highly reactive gas (at standard conditions) and has a sharp irritating odour.It is only reasonably stable at low temperatures (−80 °C). It must therefore always be prepared for each use and processed immediately, otherwise a dimerization to diketene occurs or it reacts to polymers that are difficult to handle.
Cyclohexenone is an organic compound which is a versatile intermediate used in the synthesis of a variety of chemical products such as pharmaceuticals and fragrances. [2] It is colorless liquid, but commercial samples are often yellow.
Density: 0.7739 g/ml (liquid); 0.996 g/ml (solid) Melting point: ... Cyclohexyl (C 6 H 11) is the alkyl substituent of cyclohexane and is abbreviated Cy. [6] Production
114,19 g·mol −1 Appearance colorless liquid with a smell of alcohol [1] Density: 0,9339 g·cm −3 [2] Melting point: 19 °C (66 °F) [1] Boiling point:
Benzene is converted to cyclohexylbenzene by acid-catalyzed alkylation with cyclohexene. [6] Cyclohexylbenzene is a precursor to both phenol and cyclohexanone. [7]Hydration of cyclohexene gives cyclohexanol, which can be dehydrogenated to give cyclohexanone, a precursor to caprolactam.
[1] It is produced industrially by the hydrogenation of cyclohexanone in the presence of hydrogen sulfide over a metal sulfide catalyst: C 6 H 10 O + H 2 S + H 2 → C 6 H 11 SH + H 2 O. It is also obtained by the addition of hydrogen sulfide to cyclohexene in the presence of nickel sulfide. [2]
1-Ethynylcyclohexanol (ECX) is an alkynyl alcohol derivative which is both a synthetic precursor to, and an active metabolite of the tranquilizer ethinamate, and has similar sedative, anticonvulsant and muscle relaxant effects. It has been sold as a designer drug, first being identified in the UK in March 2012. [1] [2] [3] [4]